Tenecteplase, 0.4 mg/kg, in Moderate and Severe Acute Ischemic Stroke: A Pooled Analysis of NOR-TEST and NOR-TEST 2A.

J Am Heart Assoc · 2023 · PMC10757511 · PMID 37830342

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

showed a trendP =0.051so close (0.05 < p ≤ 0.1)

In the pooled population with moderate and severe stroke, the ITT analysis showed a trend toward higher rates of any ICH and sICH in patients treated with tenecteplase (OR, 1.53 [95% CI, 0.99–2.66]; P =0.051 and OR, 2.51 [95% CI, 0.98–6.44]; P =0.054, respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.